Our previous studies have already demonstrated the beneficial effects of OXT in mitigating DSS-induced intestinal injury by inducing prostaglandin E2 release [36], as well as its regulatory roles in macrophage polarization [37], and dendritic cell tolerance [38] to alleviate DSS-induced colitis. This evidence concerns the gene OXT and colitis.